Interactions between clinical factors, p16, and cyclin‐D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Head and Neck

• Publication date

  2015-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hed.23803PMID 24953865
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• J OURNAL OF C LINICAL O NCOLOGY Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

  2014cited by this paper
• Viral load, physical status, and E6/E7 mRNA expression of human papillomavirus in head and neck squamous cell carcinoma

  2013cited by this paper
• Cyclin D1-a prognostic marker in oropharyngeal squamous cell carcinoma that is tightly associated with high-risk human papillomavirus status.

  2013cited by this paper
• p16 immunohistochemistry alone is a better prognosticator in tonsil cancer than human papillomavirus in situ hybridization with or without p16 immunohistochemistry

  2013cited by this paper
• Head and Neck Cancer: A Multidisciplinary Approach

  2013cited by this paper
• Survival and prognostic factors of different sites of head and neck cancer: an analysis from Thailand.

  2012cited by this paper
• Transcriptionally‐active high‐risk human papillomavirus is rare in oral cavity and laryngeal/hypopharyngeal squamous cell carcinomas – a tissue microarray study utilizing E6/E7 mRNA in situ hybridization

  2012cited by this paper
• The molecular biology of head and neck cancer

  2011cited by this paper
• The Mutational Landscape of Head and Neck Squamous Cell Carcinoma

  2011cited by this paper
• Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1

  2011cited by this paper
• Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site.

  2011cited by this paper
• Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice

  2011cited by this paper
• Use of cyclin D1 in conjunction with human papillomavirus status to predict outcome in oropharyngeal cancer

  2011cited by this paper
• Human papillomavirus and survival of patients with oropharyngeal cancer.

  2010cited by this paper
• Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis.

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• Treatment results for hypopharyngeal cancer by different treatment strategies and its secondary primary- an experience in Taiwan

  2010cited by this paper
• p16 Positive Oropharyngeal Squamous Cell Carcinoma:An Entity With a Favorable Prognosis Regardless of Tumor HPV Status

  2010cited by this paper
• Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma.

  2009cited by this paper
• Cigarette smoking among adults and trends in smoking cessation - United States, 2008.

  2009cited by this paper
• The Changing Face of Head and Neck Cancer in the 21st Century: The Impact of HPV on the Epidemiology and Pathology of Oral Cancer

  2009cited by this paper
• P21Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis

  2009cited by this paper
• Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

  2008cited by this paper
• Lower prevalence but favorable survival for human papillomavirus-related squamous cell carcinoma of tonsil in Taiwan.

  2008cited by this paper
• Site-Specific Molecular Signatures Predict Aggressive Disease in HNSCC

  2008cited by this paper
• A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen

  2007cited by this paper
• Prognostic significance of cyclin D1 and p16 in patients with intermediate‐risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy

  2007cited by this paper
• EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil.

  2007cited by this paper
• New evidence for geographic variation in the role of human papillomavirus in tonsillar carcinogenesis

  2007cited by this paper
• EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil.

  2006cited by this paper
• Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.

  2006cited by this paper
• Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population

  2006cited by this paper
• Phenotypic alterations in Rb pathway have more prognostic influence than p53 pathway proteins in oral carcinoma

  2005cited by this paper
• Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma.

  2005cited by this paper
• Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

  2005cited by this paper
• Trends in incidence and prognosis for head and neck cancer in the United States: A site‐specific analysis of the SEER database

  2005cited by this paper
• The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil

  2004cited by this paper
• Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

  2003cited by this paper
• Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

  2000cited by this paper
• Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.

  1999cited by this paper
• Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control.

  1998cited by this paper
• Role of the p16 tumor suppressor gene in cancer.

  1998cited by this paper
• Molecular biology of head and neck cancer.

  1994influential reference
• Risk Adjustment in Outcome Assessment: the Charlson Comorbidity Index

  1993cited by this paper
• Toxicity and response criteria of the Eastern Cooperative Oncology Group

  1982cited by this paper

• The effect of HPV DNA and p16 status on the prognosis of patients with hypopharyngeal carcinoma: a meta-analysis

  2022cites this paper
• The Impact of HPV DNA/p16 in Laryngeal/Hypopharyngeal Cancer: a Systematic Review and Meta-analysis.

  2021cites this paper
• Phase II study of nimotuzumab (TheraCim‐hR3) concurrent with cisplatin/radiotherapy in patients with locally advanced head and neck squamous cell carcinoma

  2021cites this paper
• Screening von Kopf-Hals-Tumoren

  2020cites this paper
• Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden.

  2019cites this paper
• p16 as a prognostic factor for the response to induction chemotherapy in advanced hypopharyngeal squamous cell carcinoma.

  2018cites this paper
• Human papillomavirus and oropharyngeal cancer in British Columbia

  2018cites this paper
• High-risk HPV genotypes and P16INK4a expression in a cohort of head and neck squamous cell carcinoma patients in Singapore

  2016cites this paper
• p16 and p53 expression status in head and neck squamous cell carcinoma: a correlation with histological, histoprognostic and clinical parameters.

  2016cites this paper
• Carcinomas of the Head and Neck

  2015cites this paper
• p 16 as a prognostic factor for the response to induction chemotherapy in advanced hypopharyngeal squamous cell carcinoma

  year unknowncites this paper